SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-22-007083
Filing Date
2022-02-11
Accepted
2022-02-11 17:21:43
Documents
1
Group Members
VIVO CAPITAL FUND IX, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea155472-13ga1vivo_avadel.htm SC 13G/A 73291
  Complete submission text file 0001213900-22-007083.txt   74903
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Subject) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50223 | Film No.: 22622824
SIC: 2834 Pharmaceutical Preparations

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity, LLC (Filed by) CIK: 0001728970 (see all company filings)

IRS No.: 823132352 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A